Literature DB >> 1715572

Expression of two different forms of fibroblast growth factor receptor 1 in different mouse tissues and cell lines.

O Bernard1, M Li, H H Reid.   

Abstract

The fibroblast growth factor receptors (FGFRs) form a multigene family of at least four members, all having extracellular regions consisting of either two or three immunoglobin-like (Ig-like) domains. By RNase protection analysis we have analyzed the expression of FGFR-1 mRNA in various tissues and cell lines and demonstrated that all of the cell lines studied expressed at least two different forms of the FGFR-1 at similar levels. Although muscle and heart express forms having either two [FGFR-1 short (FGFR-1S)] or three [FGFR-1 long (FGFR-1L)] Ig-like domains, the developing brain and adult brain express only mRNA encoding the longer form. The two forms of the receptor were characterized further by stably introducing expression vectors expressing them into Rat-2 fibroblasts and FDC-P1 myeloid cells. Treatment of the transfected Rat-2 cells with acidic FGF (aFGF) or basic FGF (bFGF) resulted in focus formation. The transformed phenotype was observed even without addition of ligand after growth in culture for greater than 2 months. Cross-linking of 125I-labeled bFGF (125I-bFGF) to Rat-2 cells expressing either FGFR-1L or FGFR-1S yielded two similar complexes of 150 and 110 kDa. Although Rat-2 cells expressing FGFR-1L yielded similar complexes with 125I-labeled aFGF (125I-aFGF), only the 150-kDa complex was formed with cells expressing FGFR-1S. The 150-kDa complex was also observed when 125I-aFGF or 125I-bFGF was cross-linked to FDC-P1 cells expressing FGFR-1L. Significantly, these complexes were only observed when heparin was present in the cross-linking reaction. FDC-P1 cells expressing FGFR-1 bound aFGF and bFGF with high affinity but only in the presence of heparin. The factor dependence of these cells could be switched from interleukin 3 to FGF in the presence of heparin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715572      PMCID: PMC52354          DOI: 10.1073/pnas.88.17.7625

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.

Authors:  K Keegan; D E Johnson; L T Williams; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 2.  The heparin-binding (fibroblast) growth factor family of proteins.

Authors:  W H Burgess; T Maciag
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

Review 3.  Signal transduction by the platelet-derived growth factor receptor.

Authors:  L T Williams
Journal:  Science       Date:  1989-03-24       Impact factor: 47.728

4.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein.

Authors:  R M Kris; I Lax; W Gullick; M D Waterfield; A Ullrich; M Fridkin; J Schlessinger
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

5.  Expression of the murine fibroblast growth factor 5 gene in the adult central nervous system.

Authors:  O Haub; B Drucker; M Goldfarb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop.

Authors:  T Miki; T P Fleming; D P Bottaro; J S Rubin; D Ron; S A Aaronson
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

7.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation.

Authors:  S C Thornton; S N Mueller; E M Levine
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

8.  Developmental and regional expression of basic fibroblast growth factor mRNA in the rat central nervous system.

Authors:  P Ernfors; P Lönnerberg; C Ayer-LeLievre; H Persson
Journal:  J Neurosci Res       Date:  1990-09       Impact factor: 4.164

9.  FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.

Authors:  J Partanen; T P Mäkelä; E Eerola; J Korhonen; H Hirvonen; L Claesson-Welsh; K Alitalo
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  Expression of FGF receptor gene in rat development.

Authors:  A Wanaka; J Milbrandt; E M Johnson
Journal:  Development       Date:  1991-02       Impact factor: 6.868

View more
  10 in total

1.  Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.

Authors:  A Mansukhani; P Dell'Era; D Moscatelli; S Kornbluth; H Hanafusa; C Basilico
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.

Authors:  Lin Feng; Wu-Xiang Liao; Quan Luo; Hong-Hai Zhang; Wen Wang; Jing Zheng; Dong-Bao Chen
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

3.  Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells.

Authors:  P Savagner; A M Vallés; J Jouanneau; K M Yamada; J P Thiery
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

4.  Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.

Authors:  D Aviezer; A Yayon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  Synergistic suppression: anomalous inhibition of the proliferation of factor-dependent hemopoietic cells by combination of two colony-stimulating factors.

Authors:  D Metcalf; N A Nicola; N M Gough; M Elliott; G McArthur; M Li
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  FDC-P1 myeloid cells engineered to express fibroblast growth factor receptor 1 proliferate and differentiate in the presence of fibroblast growth factor and heparin.

Authors:  M Li; O Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.

Authors:  W Casscells; D A Lappi; B B Olwin; C Wai; M Siegman; E H Speir; J Sasse; A Baird
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Identification of a cysteine-rich receptor for fibroblast growth factors.

Authors:  L W Burrus; M E Zuber; B A Lueddecke; B B Olwin
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

9.  Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.

Authors:  Giacomo Volpe; Pierre Cauchy; David S Walton; Carl Ward; Daniel Blakemore; Rachael Bayley; Mary L Clarke; Luisa Schmidt; Claus Nerlov; Paloma Garcia; Stéphanie Dumon; Florian Grebien; Jon Frampton
Journal:  Life Sci Alliance       Date:  2019-03-15

10.  Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.

Authors:  B B Olwin; A Rapraeger
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.